IN VITRO EFFECT OF ACETYLSALICYLIC ACID ON CALCIUM OXALATE CRYSTALLIZATION: AN APPROACH TO ANTILITHIASIS
Keywords:
Urolithiasis, Calcium oxalate, Crystallization, Acetylsalicylic acid, InhibitionAbstract
Objective: In recent years, significant progress has been made in identifying and counting physico-chemical processes involved in urinary stone formation. The ability of urine to inhibit calcium oxalate crystallization is considered an important mechanism against stone formation. Several natural substances were tested to inhibit calcium oxalate crystallization. In the present study, we evaluate the effects of acetylsalicylic acid, also known as Aspirin, as an inhibitor of calcium oxalate crystallization in vitro.
Methods: The nucleation and aggregation of calcium oxalate crystals were studied using turbidimetric 400-sec time course measurements of optic density at 620 nm after mixing solutions containing calcium chloride and sodium oxalate at room temperature, pH 5.7. The formation of crystals is induced by the addition of the oxalate to calcium solution. The effects on calcium oxalate crystal growth of acetylsalicylic acid with various concentrations were examined. The maximum increase of optic density in the course of time reflects maximum rate of formation of new particles. After reaching equilibrium, a progressive decrease of optic density with time is observed. Rate of aggregation is derived from the maximum decrease in optic density.
Results: The results showed that if a concentration of acetylsalicylic acid is more than 1,66 mM both rate of formations of new particles and Rate of aggregation decreased (P<0.05).
Conclusion: acetylsalicylic acid has a significant effect on nucleation as well as on crystal growth stage; consequently, it inhibits the crystal formation of calcium oxalate urinary lithiasis.
ÂÂ
Downloads
References
Strope SA, Wolf JS, Hollenbeck BK. Changes in gender distribution of urinary stone disease. Urol 2010;75(3):543-6.
Benramdane L, Bouatia M, Idrissi MOB, Draoui M. Infrared analysis of urinary stones, using a single reflection accessory and KBr pallet transmission. Spectrosc Lett 2008;41:72-80.
Bensatal A, Ouahrani MR. Inhibition of crystallization of calcium oxalate by the extraction of Tamarix gallica L. Urol Res 2008;36:283-7.
Kavanagh JP. In vitro calcium oxalate crystallisation methods. Urol Res 2006;34:139-45.
Chauhan CK, Joshi MJ. Growth inhibition of Struvite crystals in the presence of juice of Citrus medica Linn. Urol Res 2008;36:265-73.
KulaksizoÄŸlu S, Sofikerim M, Cevik C. In vitro effect of lemon and orange juices on calcium oxalate crystallization. Int Urol Nephrol 2008;40:589-94.
Spivacow FR, Negri AL, Polonsky A, Del Valle EE. Long-term treatment of renal lithiasis with potassium citrate. Urol 2010;76(6):1346-9.
Prasad KVSRG, Sujatha D, Bharti K. Herbal drugs in urolithiasis: a review. Pharmacog Rev 2007;1(1):175-8.
Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ. The Role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU 2007;5:126-36.
Driouch A, Djelloul A, Kaid-Omar Z, Semmoud A, Rais A, Addou A. Optimized experimental design for the inhibition of calcium oxalate using a turbidimetrical model. Asia-Pac J Chem Eng 2008;3:425-31.
Prachi K, Vinod KM, kakkar A, Neetu B, Rajendra S. Study on in vitro anti-lithiatic activity of Phyllanthus niruri linn. Leaves by homogenous precipitation and turbiditory method. Int J Pharm Pharm Sci 2014;6(4):124-7.
Surendra KP, Kartik C, Ranjit H. In-vitro calcium oxalate crystallization inhibition by Achyranthes indica linn. Hydroalcoholic extract: An approach to antilithiasis. Int J Pharm Bio Sci 2011;2(1):432-7.
Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol ‎2009;181(3):1140-4.
Singh SK, Aggarwal KP, Tandon S, Tandon C. Proteomic analysis of human calcium oxalate renal stone by 2-D PAGE and in vitro analysis of bioactivity of the proteins. EAU 2012;11(1, Suppl 1):855.
Aggarwal KP, Tandon S, Naik PK, Singh SK, Tandon C. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis. Clin Chim Acta 2013;415(16):181-90.
Emel A, Mualla O. inhibition of calcium oxalate monohydrate crystal growth using polyelectrolytes. J Cryst Growth 2007;307:137-44.
Atmani F, Sadki C, Aziz M, Mimouni M, Hacht B. Cynodon dactylon extract as a preventive and curative agent in experimentally induced nephrolithiasis. Urol Res 2009;37(2):75-82.